Differential Regulation of Dopamine Transporter after Chronic Self-administration of Bupropion and Nomifensine
Authors:
- Bruce LadenheimBLBruce Ladenheim
- Jean Lud CadetJCJean Lud Cadet
- 1 April 1997
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 281 (1) , 508-513
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication developmentMolecular Neurobiology, 1995
- Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in ratsPsychopharmacology, 1995
- Rate of binding of various inhibitors at the dopamine transporter in vivoPsychopharmacology, 1995
- Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drugPsychopharmacology, 1995
- Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sitesNaunyn-Schmiedeberg's Archives of Pharmacology, 1995
- Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: Preliminary evidence for different binding domainsNeurochemical Research, 1994
- Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolamPsychopharmacology, 1993
- A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaineBiochemical Pharmacology, 1992
- Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropineEuropean Journal of Pharmacology, 1987
- Self-administration of psychoactive substances by the monkeyPsychopharmacology, 1969